Allergan urges shareholders to reject Valeant Pharmaceuticals takeover offer
MONTREAL - Allergan Inc. urged its shareholders Monday to reject a hostile takeover offer by Valeant Pharmaceuticals International Inc. (TSX:VRX) in the latest step in the bitter fight between the companies.
Allergan called the offer grossly inadequate and said it created significant risks and uncertainties for Allergan shareholders.
Valeant, which had tried to negotiate a deal to acquire Allergan, took its offer directly to the company's shareholders last week.
The company has offered US$72 in cash plus 0.83 of a Valeant share for each share of the Botox maker.
The bid values Allergan at more than US$50 billion.
The recommendation is the latest step in the takeover fight which threatens to become a prolonged battle.
Bill Ackman's Pershing Square Capital Management, which is backing the Valeant offer, is also seeking to call a special meeting of Allergan's shareholders to remove six directors.
Pershing owns 9.7 per cent of Allergan.
Read more Business News
- Shopping cart fireKelowna - 11:37 am
- Joe Rich wildfire containedKelowna - 11:28 am
- Back to schoolBC - 6:47 am
- Castanet's weekly weatherCentral Okanagan - 5:00 am
|QHR Technologies Inc||1.27||-0.10|
|Anavex Life Sciences||0.2195||-0.0035|
|Copper Mountain Mining||2.40||-0.26|
|Sunrise Resources Ltd||0.02||-0.005|
|Mission Ready Services||0.27||-0.02|
“Is this a fair offer from ICBC?”…. “How much should I settle for?”… “What is my claim worth?” These are just some of the questions I regularly get as...
Last night I was privileged to be able to speak at the Greater Westside Board of Trade business awards dinner. Photo: ContributedI talked about Innovation and Collaboration which are two very interes...
There will be a time when you will need to decide who you should appoint as executor of your Will. As well, there may be a time when you will be asked by someone to act as the executor of his or her W...